177 related articles for article (PubMed ID: 18160345)
1. Bromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitro.
Onken JE; Greer PK; Calingaert B; Hale LP
Clin Immunol; 2008 Mar; 126(3):345-52. PubMed ID: 18160345
[TBL] [Abstract][Full Text] [Related]
2.
Loganes C; Valencic E; Pin A; Marini E; Martelossi S; Naviglio S; De Leo L; Not T; Monasta L; Tommasini A; Marcuzzi A
World J Gastroenterol; 2016 Nov; 22(44):9734-9743. PubMed ID: 27956797
[TBL] [Abstract][Full Text] [Related]
3. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease.
Banks C; Bateman A; Payne R; Johnson P; Sheron N
J Pathol; 2003 Jan; 199(1):28-35. PubMed ID: 12474223
[TBL] [Abstract][Full Text] [Related]
4. A CD3-specific antibody reduces cytokine production and alters phosphoprotein profiles in intestinal tissues from patients with inflammatory bowel disease.
Vossenkämper A; Hundsrucker C; Page K; van Maurik A; Sanders TJ; Stagg AJ; Das L; MacDonald TT
Gastroenterology; 2014 Jul; 147(1):172-83. PubMed ID: 24704524
[TBL] [Abstract][Full Text] [Related]
5. In vitro study on the immunological effect of bromelain and trypsin on mononuclear cells from humans.
Barth H; Guseo A; Klein R
Eur J Med Res; 2005 Aug; 10(8):325-31. PubMed ID: 16131473
[TBL] [Abstract][Full Text] [Related]
6. Treatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel disease.
Hale LP; Greer PK; Trinh CT; Gottfried MR
Clin Immunol; 2005 Aug; 116(2):135-42. PubMed ID: 15936249
[TBL] [Abstract][Full Text] [Related]
7. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
[TBL] [Abstract][Full Text] [Related]
8. Suppression of Na+/H+ exchanger isoform-3 in human inflammatory bowel disease: lack of reversal by 5'-aminosalicylate treatment.
Siddique I; Hasan F; Khan I
Scand J Gastroenterol; 2009; 44(1):56-64. PubMed ID: 18785066
[TBL] [Abstract][Full Text] [Related]
9. Colonic explant production of IL-1and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD).
Dionne S; D'Agata ID; Hiscott J; Vanounou T; Seidman EG
Clin Exp Immunol; 1998 Jun; 112(3):435-42. PubMed ID: 9649212
[TBL] [Abstract][Full Text] [Related]
10. Modulation of VIPergic phenotype of enteric neurons by colonic biopsy supernatants from patients with inflammatory bowel diseases: Involvement of IL-6 in Crohn's disease.
Soufflet F; Biraud M; Rolli-Derkinderen M; Lardeux B; Trang C; Coron E; Bruley des Varannes S; Bourreille A; Neunlist M
Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28857361
[TBL] [Abstract][Full Text] [Related]
11. TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients.
Ślebioda TJ; Bojarska-Junak A; Stanisławowski M; Cyman M; Wierzbicki PM; Roliński J; Celiński K; Kmieć Z
Scand J Immunol; 2015 Oct; 82(4):352-60. PubMed ID: 26072972
[TBL] [Abstract][Full Text] [Related]
12. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory gene expression profiles in Crohn's disease and ulcerative colitis: a comparative analysis using a reverse transcriptase multiplex ligation-dependent probe amplification protocol.
Gologan S; Iacob R; Iancu D; Iacob S; Cotruta B; Vadan R; Catuneanu AM; Constantinescu I; Barbarii L; Gheorghe C; Diculescu M
J Crohns Colitis; 2013 Sep; 7(8):622-30. PubMed ID: 23014361
[TBL] [Abstract][Full Text] [Related]
14. Effect of an extract based on the medicinal mushroom Agaricus blazei Murill on expression of cytokines and calprotectin in patients with ulcerative colitis and Crohn's disease.
Førland DT; Johnson E; Saetre L; Lyberg T; Lygren I; Hetland G
Scand J Immunol; 2011 Jan; 73(1):66-75. PubMed ID: 21129005
[TBL] [Abstract][Full Text] [Related]
15. Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease.
Vainer B; Nielsen OH; Hendel J; Horn T; Kirman I
Cytokine; 2000 Oct; 12(10):1531-6. PubMed ID: 11023669
[TBL] [Abstract][Full Text] [Related]
16. Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease.
Zeng JQ; Xu CD; Zhou T; Wu J; Lin K; Liu W; Wang XQ
World J Gastroenterol; 2015 Jan; 21(1):187-95. PubMed ID: 25574091
[TBL] [Abstract][Full Text] [Related]
17. Tofacitinib Reprograms Human Monocytes of IBD Patients and Healthy Controls Toward a More Regulatory Phenotype.
Cordes F; Lenker E; Spille LJ; Weinhage T; Bettenworth D; Kessel C; Schmidt HH; Foell D; Varga G
Inflamm Bowel Dis; 2020 Feb; 26(3):391-406. PubMed ID: 31560043
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory cytokines in exhaled breath condensate in children with inflammatory bowel diseases.
Krenke K; Peradzyńska J; Lange J; Banaszkiewicz A; Łazowska-Przeorek I; Grzela K; Radzikowski A; Kulus M
Pediatr Pulmonol; 2014 Dec; 49(12):1190-5. PubMed ID: 24339443
[TBL] [Abstract][Full Text] [Related]
19. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease.
Shioya M; Nishida A; Yagi Y; Ogawa A; Tsujikawa T; Kim-Mitsuyama S; Takayanagi A; Shimizu N; Fujiyama Y; Andoh A
Clin Exp Immunol; 2007 Sep; 149(3):480-6. PubMed ID: 17590175
[TBL] [Abstract][Full Text] [Related]
20. The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells.
Panja A; Goldberg S; Eckmann L; Krishen P; Mayer L
J Immunol; 1998 Oct; 161(7):3675-84. PubMed ID: 9759892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
